Join Professor Jean-Yves Blay as he presents findings from the largest nationwide study of liposarcomas, encompassing 11,000+ patients from the NETSARC+ registry. This session will explore the clinical presentation, management, and outcomes of the diverse histological subtypes of liposarcoma, including well-differentiated, dedifferentiated, myxoid, pleomorphic, and rarer forms. Attendees will gain insights into age- and sex-related differences in incidence and prognosis, as well as the importance of specialized sarcoma centers for optimal patient care.
These webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments, please reach out to truggiero@liposarcomasupport.org
About Our Presenter:
Professor Jean-Yves Blay
Le Centre Léon Bérard, Lyon, France
Jean-Yves Blay, oncologist, is professor of Medicine at the University of Lyon I, Director General of the Cancer Center Léon Bérard in Lyon, and President of the French Federation of CCC Unicancer. His work focuses on sarcoma, rare cancers, guiding targeted treatments using genomics, and immuno-oncology. He is a researcher at the Cancer Research Center of Lyon, director of SIRIC LYRICAN+, President of the French Sarcoma Group and the Sarcoma expert network NETSARC+, director of ERN-EURACAN of the European Commission, Director of Public Policies of ESMO, and former president of the EORTC. He has co-authored more than 1000 articles & “Highly cited Researcher” since 2019.
